Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
After finishing at $19.42 in the prior trading day, Dyne Therapeutics Inc (NASDAQ: DYN) closed at $19.27, down -0.77%. In other words, the price has decreased by -$0.77 from its previous closing price. On the day, 4.44 million shares were traded. DYN stock price reached its highest trading level at $19.9599 during the session, while it also had its lowest trading level at $19.2.
Ratios:
Our goal is to gain a better understanding of DYN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.47 and its Current Ratio is at 13.47. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.17.
Raymond James Upgraded its Outperform to Strong Buy on August 25, 2025, while the target price for the stock was maintained at $35.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 05 ’25 when Kerr Douglas bought 880 shares for $20.72 per share.
Cox John bought 2,662 shares of DYN for $55,150 on Dec 05 ’25. On Dec 05 ’25, another insider, Cox John, who serves as the CEO & President of the company, sold 2,662 shares for $20.72 each. As a result, the insider received 55,157 and left with 196,877 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DYN now has a Market Capitalization of 3227711744 and an Enterprise Value of 2080810752.
Stock Price History:
The Beta on a monthly basis for DYN is 1.31, which has changed by -0.2559387 over the last 52 weeks, in comparison to a change of 0.13613915 over the same period for the S&P500. Over the past 52 weeks, DYN has reached a high of $27.59, while it has fallen to a 52-week low of $6.36. The 50-Day Moving Average of the stock is 1.36%, while the 200-Day Moving Average is calculated to be 45.27%.
Shares Statistics:
The stock has traded on average 2.94M shares per day over the past 3-months and 4219130 shares per day over the last 10 days, according to various share statistics. A total of 142.61M shares are outstanding, with a floating share count of 104.97M. Insiders hold about 26.52% of the company’s shares, while institutions hold 83.57% stake in the company. Shares short for DYN as of 1764288000 were 17458619 with a Short Ratio of 5.94, compared to 1761868800 on 15118377. Therefore, it implies a Short% of Shares Outstanding of 17458619 and a Short% of Float of 13.639999999999999.
Earnings Estimates
The performance of Dyne Therapeutics Inc (DYN) in the stock market is under the watchful eye of 10.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.82, with high estimates of -$0.65 and low estimates of -$1.0.
Analysts are recommending an EPS of between -$3.39 and -$3.83 for the fiscal current year, implying an average EPS of -$3.56. EPS for the following year is -$3.36, with 12.0 analysts recommending between -$2.73 and -$4.32.
